UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 245

Sortiert nach

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

Nature reviews. Endocrinology, 2012-08, Vol.8 (8), p.495

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus

Acta Diabetologica, 2016-12, Vol.53 (6), p.863-870

Solini, Anna

2016

Link zum Volltext

Verfügbarkeit prüfen

Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk

Cardiovascular diabetology, 2020-11, Vol.19 (1), p.196-196, Article 196

2020

Link zum Volltext

Verfügbarkeit prüfen

Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study

Acta diabetologica, 2021-04, Vol.58 (4), p.431-436

2021

Link zum Volltext

Verfügbarkeit prüfen

Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study

Cardiovascular diabetology, 2017-10, Vol.16 (1), p.138-9, Article 138

2017

Link zum Volltext

Verfügbarkeit prüfen

The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy

International journal of molecular sciences, 2021-07, Vol.22 (13), p.7110

2021

Link zum Volltext

Verfügbarkeit prüfen

The IGFBP3/TMEM219 pathway regulates beta cell homeostasis

Nature communications, 2022-02, Vol.13 (1), p.684-684, Article 684

2022

Link zum Volltext

Verfügbarkeit prüfen

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

Frontiers in endocrinology (Lausanne), 2018-11, Vol.9, p.649-649

2018

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study

Diabetes, obesity & metabolism, 2019-02, Vol.21 (2), p.252-260

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes

Journal of hypertension, 2011-09, Vol.29 (9), p.1802-1809

2011

Link zum Volltext

Verfügbarkeit prüfen

The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7447

2022

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study

BMC medicine, 2021-03, Vol.19 (1), p.66-66, Article 66

2021

Link zum Volltext

Verfügbarkeit prüfen

Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events

Cardiovascular diabetology, 2020-04, Vol.19 (1), p.46-15, Article 46

2020

Link zum Volltext

Verfügbarkeit prüfen

Female obesity: clinical and psychological assessment toward the best treatment

Frontiers in endocrinology (Lausanne), 2024, Vol.15, p.1349794-1349794

2024

Link zum Volltext

Verfügbarkeit prüfen

miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic Potential

Scientific reports, 2020-01, Vol.10 (1), p.706-706, Article 706

2020

Link zum Volltext

Verfügbarkeit prüfen

Tirzepatide and kidney function: an intriguing and promising observation

The lancet. Diabetes & endocrinology, 2022-11, Vol.10 (11), p.762-763

Solini, Anna

2022

Link zum Volltext

Verfügbarkeit prüfen

Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report

Frontiers in endocrinology (Lausanne), 2023-05, Vol.14, p.1172468

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Endocrine and metabolic diseases

Current opinion in pharmacology, 2020-12, Vol.55, p.vii-ix

Solini, Anna

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of Podocyte B7-1 in Diabetic Nephropathy

Journal of the American Society of Nephrology, 2014-07, Vol.25 (7), p.1415-1429

2014

Link zum Volltext

Verfügbarkeit prüfen

Phenotyping individuals with newly-diagnosed type 2 diabetes at risk for all-cause mortality: a single centre observational, prospective study

Diabetology and metabolic syndrome, 2020-05, Vol.12 (1), p.47-47, Article 47

2020

Link zum Volltext

Verfügbarkeit prüfen

Response to semaglutide of non-drinker subjects with type 2 diabetes

Diabetology and metabolic syndrome, 2024-05, Vol.16 (1), p.103-103

2024

Link zum Volltext

Verfügbarkeit prüfen

Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

Cardiovascular diabetology, 2024-01, Vol.23 (1), p.34-34, Article 34

2024

Link zum Volltext

Verfügbarkeit prüfen

Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study

Cardiovascular diabetology, 2022-11, Vol.21 (1), p.233-233, Article 233

2022

Link zum Volltext

Verfügbarkeit prüfen

TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1

Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2396-2401

2009

Link zum Volltext

Verfügbarkeit prüfen

High exposure to phthalates is associated with HbA1c worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study

Diabetology and metabolic syndrome, 2022-07, Vol.14 (1), p.1-100, Article 100

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(165)
Humans
(136)
Endocrinology & Metabolism
(96)
Male
(91)
Female
(89)
Type 2 Diabetes
(75)
Middle Aged
(74)
Diabetes
(73)
Biological And Medical Sciences
(47)
Diabetes Mellitus
(46)
Aged
(45)
Adult
(43)
Medical Sciences
(42)
Diabetes Mellitus, Type 2 - Complications
(35)
Risk Factors
(35)
Cardiovascular System & Cardiology
(30)
Glomerular Filtration Rate
(29)
Blood Pressure
(27)
Cardiovascular Disease
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus

Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk

Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study

Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study

The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy

The IGFBP3/TMEM219 pathway regulates beta cell homeostasis

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes

The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage

Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study

Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events

Female obesity: clinical and psychological assessment toward the best treatment

miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic Potential

Tirzepatide and kidney function: an intriguing and promising observation

Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report

Editorial: Endocrine and metabolic diseases

Role of Podocyte B7-1 in Diabetic Nephropathy

Phenotyping individuals with newly-diagnosed type 2 diabetes at risk for all-cause mortality: a single centre observational, prospective study

Response to semaglutide of non-drinker subjects with type 2 diabetes

Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study

TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1

High exposure to phthalates is associated with HbA1c worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study

Suchergebnisse filtern